Latest News
Web Date: October 12, 2017

Big pharma joins NIH’s Cancer Moonshot for a biomarker hunt

The National Institutes of Health announces a five-year, $215 million partnership with 11 companies to establish biomarkers for immunotherapies
Department: Business

Eleven drug companies are joining forces with the National Institutes of Health’s Cancer Moonshot mission to deliver immunotherapy to more patients in less time. A partnership launched today will expedite the discovery of cancer immunotherapy biomarkers, molecular bar codes that help doctors know how to treat a tumor and gauge how well a patient responds to a drug.

The Cancer Moonshot Task Force was initiated by former President Barack Obama in February 2016 and initially . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society